Jagsonpal Pharmaceuticals Limited — Others, 07-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jagsonpal Pharmaceuticals has received a certificate from its registrar, MCS Share Transfer Agent, confirming that all securities submitted for dematerialization during the quarter were verified, cancelled, and substituted with the depository's name in the records within 15 days. The dematerialized securities are listed on the same stock exchanges as the original securities. This ensures smooth electronic trading and ownership transfer for shareholders, supporting efficient stock handling and investor convenience.